Hong Kong · Sponsored
Clinical application of ctDNA in guiding anti-EGFR therapy in the treatment of metastatic colorectal cancer
This content is sponsored. It is intended for healthcare professionals only.
In a symposium meeting held on 20 July 2022, Dr Su Pin Choo (Adjunct Associate Professor from the Duke-NUS Graduate Medical School Singapore), Prof Jeanne Tie (Associate Professor from the Peter MacCallum Cancer Centre in Melbourne), and Dr Rashid Lui (Honorary Clinical Assistant Professor from the Faculty of Medicine at The Chinese University of Hong Kong) shared their insights and clinical experience of utilising circulating tumour DNA (ctDNA) in guiding anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC).
